Factors relevant to preventing embolic stroke in patients with non-rheumatic atrial fibrillation

K M Flegel1, T A Hutchinson, P A Groome

  • 1Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.

Insights

Anticoagulant therapy offers benefits for most patients with non-rheumatic atrial fibrillation, preventing embolic stroke. Individual patient preferences for avoiding stroke versus bleeding risks significantly influence treatment decisions.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Physicians face a dilemma regarding anticoagulant use in non-rheumatic atrial fibrillation to prevent embolic stroke.
  • Ongoing randomized trials may not fully resolve treatment decisions due to unaddressed patient-specific factors.

Purpose of the Study:

  • To determine the overall benefit of anticoagulants in non-rheumatic atrial fibrillation.
  • To identify crucial factors influencing anticoagulant therapy decisions beyond randomized trial parameters.

Main Methods:

  • Utilized existing knowledge of non-rheumatic atrial fibrillation.
  • Employed a method to elicit patient-derived weights for stroke avoidance versus bleeding risk.
  • Analyzed benefits using standard assumptions and sensitivity analyses for various clinical parameters.

Main Results:

  • Anticoagulants demonstrated an expected benefit for all subjects, ranging from 5.4 to 46.7 lives saved per 1000 patients.
  • Benefit persisted across sensitivity analyses for stroke prevention and intracranial hemorrhage rates.
  • Benefit diminished for some subjects when considering different baseline stroke rates and major bleeding impacts.

Conclusions:

  • Crucial decision-making factors, such as patient-valued trade-offs between stroke and bleeding, are not typically measured in randomized trials.
  • Individualized assessment of patient preferences is paramount in determining the net benefit of anticoagulation.
  • Anticoagulant therapy is likely beneficial for most patients with non-rheumatic atrial fibrillation.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...